Chandra Bhagat Pharma Limited (BOM:542934)

India · Delayed Price · Currency is INR

49.90

-2.60 (-4.95%)

At close: Aug 14, 2026

-9.27% (1Y)

Market Cap	376.50M -9.3%
Revenue (ttm)	1.17B +28.5%
Net Income	30.46M +255.1%
EPS	4.04 +255.1%
Shares Out	7.55M
PE Ratio	12.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	50.00
Previous Close	52.50
Day's Range	49.90 - 50.00
52-Week Range	29.70 - 59.00
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Chandra Bhagat Pharma

Chandra Bhagat Pharma Limited, a pharmaceutical company, markets pharmaceutical critical care and health care products in India and internationally. The company offers pharmaceutical formulations, including intravenous and intramuscular injections, oral solids, tablets, capsules, liquid orals, syrup suspensions, injectable liquids, powders, lyophilized ampoules, vials, prefilled syringes, and small and large volume parenteral for various therapeutic categories, such as anti-cancer, anti-infective, antibiotics, anesthesia, hormones, orthopedic, ... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1944

Employees 45

Stock Exchange Bombay Stock Exchange

Ticker Symbol 542934

Full Company Profile

Financial Performance

In fiscal year 2026, Chandra Bhagat Pharma's revenue was 1.17 billion, an increase of 28.53% compared to the previous year's 908.56 million. Earnings were 30.46 million, an increase of 255.11%.

Financial Statements